Characteristics | Complete (n = 25) | Failure (n = 4) | P value |
---|---|---|---|
Age, years | 64.9 ± 8.19 | 69.5 ± 2.69 | 0.182 |
Sex, male (n) [%] | 21/25 (80.7) | 2/4 (50.0) | 0.180† |
Duration of hemodialysis (years) | 16.1 ± 9.5 | 15.3 ± 10.4 | 0.393* |
Previous treatment (n) [%] | |||
Naïve | 19/25 (76.0) | 1/4 (25.0) | 0.076† |
Relapse and non-viral response | 6/25 (24.0) | 3/4 (75.0) | |
Liver cirrhosis (n) [%] | 6/25 (24.0) | 3/4 (75.0) | 0.076† |
Serum HCV-RNA levels (log10 IU/mL) | 5.06 ± 0.99 | 5.88 ± 0.28 | 0.158* |
≥5.0 log10 IU/mL (n) [%] | 16/25 (64.0) | 4/4 (100) | 0.280† |
≥5.5 log10 IU/mL (n) [%] | 9/25 (36) | 4/4 (100) | 0.030† |
NS5A inhibitor RAVs (n) [%] | 2/25 (8) | 0/4 (0) | 1.000† |